CPAP vs GLP-1 Drugs vs Combination for Sleep Apnea: A Network Meta-Analysis | Research

The takeaway

Network meta-analysis compares CPAP, GLP-1 receptor agonists, and their combination for obstructive sleep apnea, evaluating respiratory, sleepiness, and metabolic outcomes.

CPAP vs GLP-1 RA comparison
First network meta-analysis comparing these treatments head-to-head for OSA outcomes

What the researchers found

Network meta-analysis compared CPAP, GLP-1 RAs, and combination therapy for OSA, evaluating the primary endpoint of AHI along with sleepiness and metabolic outcomes.

Why it matters

Millions with OSA struggle with CPAP adherence. If GLP-1 drugs provide comparable or complementary benefits, patients could have alternatives or combination options for better sleep apnea management.

How the study worked

Network meta-analysis of randomized trials from PubMed, Embase, and CENTRAL through August 2025; comparing CPAP, GLP-1 RAs, combination, and no treatment.

What this study cannot tell us

Limited number of GLP-1 RA trials specifically in OSA; indirect comparisons in network meta-analysis; heterogeneity in OSA severity across studies.

How to read the evidence

Network meta-analysis of RCTs — highest evidence synthesis for comparative effectiveness, though limited by available trials.

When this study was published

Published in 2026 with evidence through August 2025, capturing the latest data including tirzepatide OSA trials.

The bigger picture

This positions GLP-1 drugs as potential game-changers for sleep medicine — not replacing CPAP but potentially offering complementary or alternative management for the obesity-driven component of OSA.

Questions still open

Could GLP-1 drugs replace CPAP for mild-to-moderate OSA where weight is the primary driver?
Does the combination of CPAP plus GLP-1 drugs provide synergistic benefits for severe OSA?

Common questions

Can GLP-1 drugs treat sleep apnea?

GLP-1 drugs reduce weight, which is the primary driver of OSA in many patients. This meta-analysis compares their effectiveness to CPAP — the current standard treatment — to determine if they offer a viable alternative or addition.

Is combination CPAP plus GLP-1 drugs better than either alone?

This network meta-analysis examined that question. CPAP mechanically keeps airways open while GLP-1 drugs reduce the fat that causes airway collapse — addressing different aspects of the problem simultaneously.

Read the original research

Comparative effectiveness of continuous positive airway pressure and glucagon-like peptide-1 receptor agonists in obstructive sleep apnea: A network meta-analysis of randomised trials.

Diabetes, obesity & metabolism

View on PubMed ↗Publisher’s paper ↗

Citation

Chiappa, Gaspar R; Santos, Paula C N; Cavalcante, Deivyd Vieira Silva; Sá Filho, Alberto Souza; Prado, Natalia; Lombardo, Katia Marques; Sequero, Pedro Sanchez; Esquinas, Antonio M. (2026). Comparative effectiveness of continuous positive airway pressure and glucagon-like peptide-1 receptor agonists in obstructive sleep apnea: A network meta-analysis of randomised trials.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70572